Categories: BioTechDevelopmentHomeHumanPlatformProductStorage
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.11.2011 | Series D | $26.5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 17.11.2011 | Oxyrane Raises $26.5M Series D |
Forbion Capital Partners announced that it has invested in Oxyrane UK Limited, a biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases.
>> Click here for mo... |
| 17.11.2011 | Oxyrane Raises $26.5M in Series D Funding | Oxyrane UK Limited, a Manchester, England, UK-based biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, has raised $26.5m in Series D funding round.
Backers inclu... |
Reviews 0
